BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cernea S, Onișor D. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. World J Gastroenterol 2023; 29(2): 286-309 [PMID: 36687124 DOI: 10.3748/wjg.v29.i2.286]
URL: https://www.wjgnet.com/1948-5182/full/v29/i2/286.htm
Number Citing Articles
1
Sizhe Liu, Le Kang, Yagang Song, Mingsan Miao. Role of the HIF-1α/BNIP3 Signaling Pathway in Recurrent Hepatocellular Carcinoma and the Mechanism of Traditional Chinese MedicineJournal of Hepatocellular Carcinoma 2023; : 893 doi: 10.2147/JHC.S409292
2
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic InterplayLife 2024; 14(2): 272 doi: 10.3390/life14020272
3
Carmen Yagüe-Caballero, Diego Casas-Deza, Andrea Pascual-Oliver, Silvia Espina-Cadena, Jose M. Arbones-Mainar, Vanesa Bernal-Monterde. MASLD-Related Hepatocarcinoma: Special Features and ChallengesJournal of Clinical Medicine 2024; 13(16): 4657 doi: 10.3390/jcm13164657
4
Centura R. Anbarasu, Sophia Williams-Perez, Ernest R. Camp, Derek J. Erstad. Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular CarcinomaCancers 2024; 16(16): 2773 doi: 10.3390/cancers16162773